The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cancer Cell Biopsy Service Market Research Report 2025

Global Cancer Cell Biopsy Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1719646

No of Pages : 87

Synopsis
Market Analysis and Insights: Global Cancer Cell Biopsy Service Market
The global Cancer Cell Biopsy Service market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Incisional Biopsy accounting for % of the Cancer Cell Biopsy Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Cancer Cell Biopsy Service market size is valued at US$ million in 2021, while the North America and Europe Cancer Cell Biopsy Service are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cancer Cell Biopsy Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Cell Biopsy Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Cell Biopsy Service market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Cell Biopsy Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Cell Biopsy Service market.
Global Cancer Cell Biopsy Service Scope and Market Size
Cancer Cell Biopsy Service market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Cell Biopsy Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type

  • Incisional Biopsy
  • Needle Biopsy

Segment by Application

  • Hospital
  • Clinic

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

By Company

  • ANGLE
  • Fluxion Biosciences
  • Inivata
  • GRAIL
  • Guardant Health
  • Caris
  • Liquid Biopsy Labs
  • DermTech
  • QIAGEN
  • Lucence
  • Biocept
  • CELLSEARCH
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Cell Biopsy Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Incisional Biopsy
1.2.3 Needle Biopsy
1.3 Market by Application
1.3.1 Global Cancer Cell Biopsy Service Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Cell Biopsy Service Market Perspective (2017-2028)
2.2 Cancer Cell Biopsy Service Growth Trends by Region
2.2.1 Cancer Cell Biopsy Service Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Cell Biopsy Service Historic Market Size by Region (2017-2022)
2.2.3 Cancer Cell Biopsy Service Forecasted Market Size by Region (2023-2028)
2.3 Cancer Cell Biopsy Service Market Dynamics
2.3.1 Cancer Cell Biopsy Service Industry Trends
2.3.2 Cancer Cell Biopsy Service Market Drivers
2.3.3 Cancer Cell Biopsy Service Market Challenges
2.3.4 Cancer Cell Biopsy Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Cell Biopsy Service Players by Revenue
3.1.1 Global Top Cancer Cell Biopsy Service Players by Revenue (2017-2022)
3.1.2 Global Cancer Cell Biopsy Service Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Cell Biopsy Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Cell Biopsy Service Revenue
3.4 Global Cancer Cell Biopsy Service Market Concentration Ratio
3.4.1 Global Cancer Cell Biopsy Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Cell Biopsy Service Revenue in 2021
3.5 Cancer Cell Biopsy Service Key Players Head office and Area Served
3.6 Key Players Cancer Cell Biopsy Service Product Solution and Service
3.7 Date of Enter into Cancer Cell Biopsy Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Cell Biopsy Service Breakdown Data by Type
4.1 Global Cancer Cell Biopsy Service Historic Market Size by Type (2017-2022)
4.2 Global Cancer Cell Biopsy Service Forecasted Market Size by Type (2023-2028)
5 Cancer Cell Biopsy Service Breakdown Data by Application
5.1 Global Cancer Cell Biopsy Service Historic Market Size by Application (2017-2022)
5.2 Global Cancer Cell Biopsy Service Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Cell Biopsy Service Market Size (2017-2028)
6.2 North America Cancer Cell Biopsy Service Market Size by Country (2017-2022)
6.3 North America Cancer Cell Biopsy Service Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Cell Biopsy Service Market Size (2017-2028)
7.2 Europe Cancer Cell Biopsy Service Market Size by Country (2017-2022)
7.3 Europe Cancer Cell Biopsy Service Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Cell Biopsy Service Market Size (2017-2028)
8.2 Asia-Pacific Cancer Cell Biopsy Service Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Cell Biopsy Service Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Cell Biopsy Service Market Size (2017-2028)
9.2 Latin America Cancer Cell Biopsy Service Market Size by Country (2017-2022)
9.3 Latin America Cancer Cell Biopsy Service Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Cell Biopsy Service Market Size (2017-2028)
10.2 Middle East & Africa Cancer Cell Biopsy Service Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Cell Biopsy Service Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 ANGLE
11.1.1 ANGLE Company Detail
11.1.2 ANGLE Business Overview
11.1.3 ANGLE Cancer Cell Biopsy Service Introduction
11.1.4 ANGLE Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.1.5 ANGLE Recent Development
11.2 Fluxion Biosciences
11.2.1 Fluxion Biosciences Company Detail
11.2.2 Fluxion Biosciences Business Overview
11.2.3 Fluxion Biosciences Cancer Cell Biopsy Service Introduction
11.2.4 Fluxion Biosciences Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.2.5 Fluxion Biosciences Recent Development
11.3 Inivata
11.3.1 Inivata Company Detail
11.3.2 Inivata Business Overview
11.3.3 Inivata Cancer Cell Biopsy Service Introduction
11.3.4 Inivata Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.3.5 Inivata Recent Development
11.4 GRAIL
11.4.1 GRAIL Company Detail
11.4.2 GRAIL Business Overview
11.4.3 GRAIL Cancer Cell Biopsy Service Introduction
11.4.4 GRAIL Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.4.5 GRAIL Recent Development
11.5 Guardant Health
11.5.1 Guardant Health Company Detail
11.5.2 Guardant Health Business Overview
11.5.3 Guardant Health Cancer Cell Biopsy Service Introduction
11.5.4 Guardant Health Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.5.5 Guardant Health Recent Development
11.6 Caris
11.6.1 Caris Company Detail
11.6.2 Caris Business Overview
11.6.3 Caris Cancer Cell Biopsy Service Introduction
11.6.4 Caris Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.6.5 Caris Recent Development
11.7 Liquid Biopsy Labs
11.7.1 Liquid Biopsy Labs Company Detail
11.7.2 Liquid Biopsy Labs Business Overview
11.7.3 Liquid Biopsy Labs Cancer Cell Biopsy Service Introduction
11.7.4 Liquid Biopsy Labs Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.7.5 Liquid Biopsy Labs Recent Development
11.8 DermTech
11.8.1 DermTech Company Detail
11.8.2 DermTech Business Overview
11.8.3 DermTech Cancer Cell Biopsy Service Introduction
11.8.4 DermTech Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.8.5 DermTech Recent Development
11.9 QIAGEN
11.9.1 QIAGEN Company Detail
11.9.2 QIAGEN Business Overview
11.9.3 QIAGEN Cancer Cell Biopsy Service Introduction
11.9.4 QIAGEN Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.9.5 QIAGEN Recent Development
11.10 Lucence
11.10.1 Lucence Company Detail
11.10.2 Lucence Business Overview
11.10.3 Lucence Cancer Cell Biopsy Service Introduction
11.10.4 Lucence Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.10.5 Lucence Recent Development
11.11 Biocept
11.11.1 Biocept Company Detail
11.11.2 Biocept Business Overview
11.11.3 Biocept Cancer Cell Biopsy Service Introduction
11.11.4 Biocept Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.11.5 Biocept Recent Development
11.12 CELLSEARCH
11.12.1 CELLSEARCH Company Detail
11.12.2 CELLSEARCH Business Overview
11.12.3 CELLSEARCH Cancer Cell Biopsy Service Introduction
11.12.4 CELLSEARCH Revenue in Cancer Cell Biopsy Service Business (2017-2022)
11.12.5 CELLSEARCH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Cancer Cell Biopsy Service Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Incisional Biopsy
Table 3. Key Players of Needle Biopsy
Table 4. Global Cancer Cell Biopsy Service Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cancer Cell Biopsy Service Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cancer Cell Biopsy Service Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cancer Cell Biopsy Service Market Share by Region (2017-2022)
Table 8. Global Cancer Cell Biopsy Service Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cancer Cell Biopsy Service Market Share by Region (2023-2028)
Table 10. Cancer Cell Biopsy Service Market Trends
Table 11. Cancer Cell Biopsy Service Market Drivers
Table 12. Cancer Cell Biopsy Service Market Challenges
Table 13. Cancer Cell Biopsy Service Market Restraints
Table 14. Global Cancer Cell Biopsy Service Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cancer Cell Biopsy Service Market Share by Players (2017-2022)
Table 16. Global Top Cancer Cell Biopsy Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Cell Biopsy Service as of 2021)
Table 17. Ranking of Global Top Cancer Cell Biopsy Service Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cancer Cell Biopsy Service Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Cell Biopsy Service Product Solution and Service
Table 21. Date of Enter into Cancer Cell Biopsy Service Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Cell Biopsy Service Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cancer Cell Biopsy Service Revenue Market Share by Type (2017-2022)
Table 25. Global Cancer Cell Biopsy Service Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cancer Cell Biopsy Service Revenue Market Share by Type (2023-2028)
Table 27. Global Cancer Cell Biopsy Service Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cancer Cell Biopsy Service Revenue Market Share by Application (2017-2022)
Table 29. Global Cancer Cell Biopsy Service Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cancer Cell Biopsy Service Revenue Market Share by Application (2023-2028)
Table 31. North America Cancer Cell Biopsy Service Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Cancer Cell Biopsy Service Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Cancer Cell Biopsy Service Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Cancer Cell Biopsy Service Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Cancer Cell Biopsy Service Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Cancer Cell Biopsy Service Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Cancer Cell Biopsy Service Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Cancer Cell Biopsy Service Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Cancer Cell Biopsy Service Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Cancer Cell Biopsy Service Market Size by Country (2023-2028) & (US$ Million)
Table 41. ANGLE Company Detail
Table 42. ANGLE Business Overview
Table 43. ANGLE Cancer Cell Biopsy Service Product
Table 44. ANGLE Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 45. ANGLE Recent Development
Table 46. Fluxion Biosciences Company Detail
Table 47. Fluxion Biosciences Business Overview
Table 48. Fluxion Biosciences Cancer Cell Biopsy Service Product
Table 49. Fluxion Biosciences Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 50. Fluxion Biosciences Recent Development
Table 51. Inivata Company Detail
Table 52. Inivata Business Overview
Table 53. Inivata Cancer Cell Biopsy Service Product
Table 54. Inivata Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 55. Inivata Recent Development
Table 56. GRAIL Company Detail
Table 57. GRAIL Business Overview
Table 58. GRAIL Cancer Cell Biopsy Service Product
Table 59. GRAIL Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 60. GRAIL Recent Development
Table 61. Guardant Health Company Detail
Table 62. Guardant Health Business Overview
Table 63. Guardant Health Cancer Cell Biopsy Service Product
Table 64. Guardant Health Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 65. Guardant Health Recent Development
Table 66. Caris Company Detail
Table 67. Caris Business Overview
Table 68. Caris Cancer Cell Biopsy Service Product
Table 69. Caris Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 70. Caris Recent Development
Table 71. Liquid Biopsy Labs Company Detail
Table 72. Liquid Biopsy Labs Business Overview
Table 73. Liquid Biopsy Labs Cancer Cell Biopsy Service Product
Table 74. Liquid Biopsy Labs Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 75. Liquid Biopsy Labs Recent Development
Table 76. DermTech Company Detail
Table 77. DermTech Business Overview
Table 78. DermTech Cancer Cell Biopsy Service Product
Table 79. DermTech Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 80. DermTech Recent Development
Table 81. QIAGEN Company Detail
Table 82. QIAGEN Business Overview
Table 83. QIAGEN Cancer Cell Biopsy Service Product
Table 84. QIAGEN Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 85. QIAGEN Recent Development
Table 86. Lucence Company Detail
Table 87. Lucence Business Overview
Table 88. Lucence Cancer Cell Biopsy Service Product
Table 89. Lucence Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 90. Lucence Recent Development
Table 91. Biocept Company Detail
Table 92. Biocept Business Overview
Table 93. Biocept Cancer Cell Biopsy ServiceProduct
Table 94. Biocept Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 95. Biocept Recent Development
Table 96. CELLSEARCH Company Detail
Table 97. CELLSEARCH Business Overview
Table 98. CELLSEARCH Cancer Cell Biopsy ServiceProduct
Table 99. CELLSEARCH Revenue in Cancer Cell Biopsy Service Business (2017-2022) & (US$ Million)
Table 100. CELLSEARCH Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Cell Biopsy Service Market Share by Type: 2021 VS 2028
Figure 2. Incisional Biopsy Features
Figure 3. Needle Biopsy Features
Figure 4. Global Cancer Cell Biopsy Service Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Cancer Cell Biopsy Service Report Years Considered
Figure 8. Global Cancer Cell Biopsy Service Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Cancer Cell Biopsy Service Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Cancer Cell Biopsy Service Market Share by Region: 2021 VS 2028
Figure 11. Global Cancer Cell Biopsy Service Market Share by Players in 2021
Figure 12. Global Top Cancer Cell Biopsy Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Cell Biopsy Service as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Cancer Cell Biopsy Service Revenue in 2021
Figure 14. North America Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Cancer Cell Biopsy Service Market Share by Country (2017-2028)
Figure 16. United States Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Cancer Cell Biopsy Service Market Share by Country (2017-2028)
Figure 20. Germany Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Cancer Cell Biopsy Service Market Share by Region (2017-2028)
Figure 28. China Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Cancer Cell Biopsy Service Market Share by Country (2017-2028)
Figure 36. Mexico Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Cancer Cell Biopsy Service Market Share by Country (2017-2028)
Figure 40. Turkey Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Cancer Cell Biopsy Service Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. ANGLE Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 43. Fluxion Biosciences Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 44. Inivata Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 45. GRAIL Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 46. Guardant Health Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 47. Caris Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 48. Liquid Biopsy Labs Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 49. DermTech Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 50. QIAGEN Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 51. Lucence Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 52. Biocept Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 53. CELLSEARCH Revenue Growth Rate in Cancer Cell Biopsy Service Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’